BXOS110 Injection in the Treatment of Acute Ischaemic Stroke

NCT06322394 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: high-dose BXOS110
DRUG: low-dose BXOS110
DRUG: Placebo

Sponsor

Biocells (Beijing) Biotech Co.,Ltd